Boffito M - Search Results

1

Rilpivirine long-acting for the prevention and treatment of HIV infection.

Ferretti F, Boffito M. Ferretti F, et al. Among authors: boffito m. Curr Opin HIV AIDS. 2018 Jul;13(4):300-307. doi: 10.1097/COH.0000000000000474. Curr Opin HIV AIDS. 2018. PMID: 29794818 Review.

2

The pharmacokinetics of HIV protease inhibitor combinations.

Boffito M, Maitland D, Samarasinghe Y, Pozniak A. Boffito M, et al. Curr Opin Infect Dis. 2005 Feb;18(1):1-7. doi: 10.1097/00001432-200502000-00002. Curr Opin Infect Dis. 2005. PMID: 15647693 Review.

3

Pharmacokinetics and pharmacodynamics of drug interactions involving HIV-1 protease inhibitors.

Jackson A, Taylor S, Boffito M. Jackson A, et al. Among authors: boffito m. AIDS Rev. 2004 Oct-Dec;6(4):208-17. AIDS Rev. 2004. PMID: 15700619 Review.

4

Nucleoside/nucleotide reverse transcriptase inhibitor drug interactions.

Samarasinghe YP, Boffito M, Di Perri G. Samarasinghe YP, et al. Among authors: boffito m. J HIV Ther. 2004 Nov;9(4):79-86. J HIV Ther. 2004. PMID: 15731739 Review.

5

Early virologic failure in HIV-1 infected subjects on didanosine/tenofovir/efavirenz: 12-week results from a randomized trial.

Maitland D, Moyle G, Hand J, Mandalia S, Boffito M, Nelson M, Gazzard B. Maitland D, et al. Among authors: boffito m. AIDS. 2005 Jul 22;19(11):1183-8. doi: 10.1097/01.aids.0000176218.40861.14. AIDS. 2005. PMID: 15990571 Clinical Trial.

6

Host determinants of antiretroviral drug activity.

Boffito M, Winston A, Owen A. Boffito M, et al. Curr Opin Infect Dis. 2005 Dec;18(6):543-9. doi: 10.1097/01.qco.0000191507.48481.10. Curr Opin Infect Dis. 2005. PMID: 16258330 Review.

7

Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance.

Boffito M, Winston A, Jackson A, Fletcher C, Pozniak A, Nelson M, Moyle G, Tolowinska I, Hoetelmans R, Miralles D, Gazzard B. Boffito M, et al. AIDS. 2007 Jul 11;21(11):1449-55. doi: 10.1097/QAD.0b013e3282170ab1. AIDS. 2007. PMID: 17589191

8

British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.

Gazzard BG, Anderson J, Babiker A, Boffito M, Brook G, Brough G, Churchill D, Cromarty B, Das S, Fisher M, Freedman A, Geretti AM, Johnson M, Khoo S, Leen C, Nair D, Peters B, Phillips A, Pillay D, Pozniak A, Walsh J, Wilkins E, Williams I, Williams M, Youle M; BHIVA Treatment Guidelines Writing Group. Gazzard BG, et al. Among authors: boffito m. HIV Med. 2008 Oct;9(8):563-608. doi: 10.1111/j.1468-1293.2008.00636.x. HIV Med. 2008. PMID: 18826546 Free article. No abstract available.

9

Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naïve and -experienced patients.

Boffito M, Miralles D, Hill A. Boffito M, et al. HIV Clin Trials. 2008 Nov-Dec;9(6):418-27. doi: 10.1310/hct0906-418. HIV Clin Trials. 2008. PMID: 19203907 Review.

10

Prevention of atherosclerosis in patients living with HIV.

De Lorenzo F, Boffito M, Collot-Teixeira S, Gazzard B, McGregor JL, Shotliff K, Xiao H. De Lorenzo F, et al. Among authors: boffito m. Vasc Health Risk Manag. 2009;5(1):287-300. doi: 10.2147/vhrm.s5206. Epub 2009 Apr 8. Vasc Health Risk Manag. 2009. PMID: 19436663 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

348 results

Search Page